medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2020, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2020; 36 (1)

Applications of flow cytometry in the study of chronic lymphoproliferative syndromes

Triana MY, Marsán SV

Language: Spanish
References: 46
Page: 1-21
PDF size: 588.16 Kb.


ABSTRACT

Introduction: Flow cytometry is an advanced, objective and highly sensitive technique that allows simultaneous quantification and analysis of multiple cellular parameters. It is widely used in the study of malignant hemopathies. In recent years, it has proved very useful in the identification and immunophenotypic characterization of chronic lymphoproliferative syndromes. These conditions belong to a heterogeneous group of diseases characterized by monoclonal expansion of mature lymphoid cells.
Objectives: To analyze the general aspects of flow cytometry application to the study and immunophenotypic classification of chronic lymphoproliferative syndromes.
Methods: A bibliographic-documentary research about the topic was carried out. We consulted the SciELO and Pubmed databases.
Information analysis and synthesis: The technical aspects of the flow cytometry are described, from obtaining and processing the samples to the cytometer’s generating the report; as well as the technique’s application to the immunophenotypic characterization of chronic lymphoproliferative syndromes. Multiparametric flow cytometry has become one of the diagnostic methods for this syndrome. One of the main objectives of the immunophenotypic study by flow cytometry is to rule out whether this population of B cells is clonal or not.
Conclusions: Flow cytometry allows the analysis, interpretation and immunophenotypic classification of chronic lymphoproliferative syndromes. It is a useful tool that supports the diagnosis and monitoring of these patients.


REFERENCES

  1. Marsán V, del Valle L, Díaz G, Macías C. Metodología y aplicaciones de la citometría de flujo para el inmunofenotipaje de las leucemias agudas. Revista Cubana de Hematol Inmunol Hemoter. 2015;31(3):242-53.

  2. Marsán V, del Valle L, Socarrás B, Sánchez M, Macías C, Mazorra Z, et al. Validación del ultramicrométodo inmunocitoquímico (UMICIQ) para el inmunofenotipaje de la leucemia linfoide aguda pediátrica. Rev Cubana Hematol Inmunol Hemoter. 2012;28(3).

  3. Kroft, SH, Harrington AM. Flow Cytometry of B-Cell Neoplasms. Clin Lab Med. 2017;37:697-723.

  4. Pagnucco G, Vanelli L, Gervasi F. Multidimensional flow cytometry immunophenotyping of hematologic malignancy. Ann N Y Acad Sci. 2013;963:313-21.

  5. Barrena S, Almeida J, Garcia MC. Flow cytometry immunophenotyping of fine needle aspiration specimens: utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology2011; 58:906-18.

  6. Abeer M, Mohammad H, Abeer A, Bahnassy E, Shadia MS. Flow cytometric immunophenotyping (FCI) of lymphoma: correlation with histopathology and immunohistochemistry. Diag Pathol. 2008;3:43.

  7. Gudgin EJ, Erber WN. Immunophenotyping of lymphoproliferative disorders: state of the art. Pathology. 2005;37(6):457-78.

  8. Rawstron AC. Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: an European Research Initiative on CLL (ERIC) &European Society for Clinical Cell Analysis (ESCCA) Harmonisation project. Cytometry B Clin Cytom. 2018;9:121-8.

  9. San Miguel JF, Duque R, Orfao A. Utilidad del Inmunofenotipo en diagnóstico y clasificación de las leucemias crónicas. En Ruiz GJ, San Miguel JF. Actualización en Leucemias. México: Panamericana: 1996. p. 25-34.

  10. Seegmiller AC, Hsi ED, Craig FE. The current role of clinical flow cytometry in the evaluation of mature B-cell neoplasms. Cytometry B. Clin.Cytom. 2018;29:20-9.

  11. Yu G, Vergara N, Moore E, King R. Use of Flow Cytometry in the Diagnosis of Lymphoproliferative Disorders in Fluid Specimens. Diag Cytopathol. 2014;42(8):664-70.

  12. Jou JM, Krueger E. Manual de obtención, transporte y conservación de muestras biológicas en Hematología y Hemoterapia. Asociación Española de Hematología y Hemoterapia. 2003 [acceso 31/10/2020]. Disponible en: https://nucleus.usal.es/sites/default/files/servicios/citometria/g_0.1ci_ed2_guia_para_el_en vio_de_muestras_a_ci.pdf

  13. Strate B, Longdin R, Geerlings M, Bachmayer N, Cavallin M, Litwin V, et al. Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum 2017. Bioanalysis 2017;9(16). doi.org/10.4155/bio-2017-0093.

  14. Pérez JC, Santiago W, Romero H, Rodríguez JC. Fundamentos de Citometría de flujo: Su aplicación diagnóstica en la investigación biomédica y clínica. Rev Méd Univ Veracruz. 2018;18(2).

  15. Rajab A, Axler O, Leung J, Wozniak M, PorwitA. Ten-color 15-antibody flow cytometry panel for immunophenotyping of lymphocyte population. Int J Lab Hematol. 2017;39:76-85.

  16. Glier H. Standardization of 8-color flow cytometry across different flow cytometer instruments: A feasibility study in clinical laboratories in Switzerland. J Immunol Methods. 2017;(1). doi:10.1016/j.jim.2017.07.013.

  17. Hedley BD, Keeney M, Popma J, Chin-Yee I. Novel lymphocyte screening tuve using dried monoclonal antibody reagents. Cytom. Part B - Clin Cytom. 2015;88:361-70.

  18. Vogt RF Jr, Whitfield WE, Henderson LO, Hannon WH. Fluorescence intensity calibration for immunophenotyping by flow cytometry. Methods. 2000;21(3):289-96.

  19. Bossuyt X, Marti GE, Fleisher TA. Comparative analysis of whole blood lysis methods for flow cytometry. Cytom. 1997;30(3):124-33.

  20. Wang, L. and Hoffman, R.A. Standardization, calibration, and control in flow cytometry. Curr. Protoc. Cytom. 2017;79:13-27. doi: 10.1002/cpcy.14

  21. Adan A, Alizada G, Kiraz Y, Baran, Nalbant A. Flow cytometry: basic principles and applications. Crit Rev Biotechnol. 2016. DOI: 10.3109/07388551.2015.1128876

  22. Koblížek M, Lebedeva A, Karel Fišer K. Flow cytometry standard conformance testing, editing, and export tool. Cytometry Part A banner. 2018;93(8).

  23. OKaly GP, Nargund AR, Venkataswamy E, Jayanna PK, Juvva CR, Prabhudesai S. Chronic Lymphoproliferative Disorders at an Indian Tertiary Cancer Centre - The Panel Sufficiency in the Diagnosis of Chronic Lymphocytic Leukaemia. J Clin Diagn Res. 2013;7(7):1366-71. doi: 10.7860/JCDR/2013/5088.3130

  24. Pino D, Sánchez M, Marsán V, Casado I, Macías C. Aspectos generales de algunas entidades dentro de los síndromes linfoproliferativos crónicos: La leucemia linfoide crónica. Rev Cub Hematol Inmunol Hemoter. 2017;33(4).

  25. Mora A, Bosch R, Cuellar C, Puy V, Blanco L, Martino R, et al. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia. Cytometry B Clin Cytom. 2019;96(2):143-8.

  26. Zucchetto A, Bomben R, Dal Bo M. CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance. Leukemia. 2006;0:523-5.

  27. Robak T, Matutes E, Catovsky D, Zinzani PL, Buske on behalf of the ESMO Guidelines Committee, Hairycellleukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(5):100-7.

  28. Rashidi A, Fisher SI. T-cell chronic lymphocytic leukemia or small-cell variant of Tcell prolymphocytic leukemia: a historical perspective and search for consensus. Eur J Haematol. 2015;95(3):199-210. doi: 10.1111/ejh.12560

  29. Miranda-Filho A, Piñeros M, Ferlay J. Epidemiological patterns of leukaemia in 184 countries: a population-based study. Lancet Haematol 2018;5:14

  30. Laribi K, Lemaire P, Sandrini J, Baugier de Materre A. Advances in the understanding and management of T-cell prolymphocytic leukemia. Oncotarget. 2017;8(61):104664-86. doi:10.18632/oncotarget.22272

  31. Moignet and Lamy. Latest Advances in the Diagnosis and Treatment of Large Granular Lymphocytic Leukemia. 2018. Am Soc Clin Oncol Educ Book. 2018 May 23;38:616-25. doi: 10.1200/EDBK_200689

  32. Darwiche W, Gubler B, Marolleau JP, Hussein Ghamlouch H. Chronic Lymphocytic Leukemia B-Cell Normal Cellular Counterpart: Clues From a Functional Perspective. Front Immunol. 2018;9:683.

  33. Fumihiro Ishida. Aggressive NK-Cell Leukemia. Front Pediatr. 2018;6:292.

  34. Henriques A, Rodríguez CA, Criado I, Langerak A, Nieto W, Lécrevisse Q, et al. Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders. Hematological. 2014;99(5). doi:10.3324/haematol.2013.098913

  35. Sales MM, Ferreira AC, Ikoma MR, Sandes AF, Beltrame, Bacal NS, et al. Diagnosis of Chronic Lymphoproliferative Disorders by Flow Cytometry Using Four-Color Combinations for Immunophenotyping: A Proposal of the Brazilian Group of Flow Cytometry (GBCFLUX). Cytometry Part B (Clin Cytometry). 2017;92B:398-410.

  36. Evans PA, Pott C, Groenen PJ. Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia. 2007;21:207-14.

  37. Costa ES, Arroyo ME, Pedreira CE. A new automated flow cytometry data analysis approach for the diagnostic screening of neoplastic B-cell disorder in peripheral blood samples with absolute lymphocytosis. Leukemia. 2006;20:1221-30.

  38. Craig FE, Foon KA. Flow cytometric immunophenotyping for hematologic neoplasms. Blood. 2008;11(8):3941-67.

  39. Tracy I, George MD. Diagnostic Approach to Lymphocytosis. Hematologist. 2015 [acceso 31/10/2020];12(6). Disponible en: https://www.hematology.org/Thehematologist/Ask/4507.aspx

  40. Mahe E, Pugh T, Kamel-Reid S. T cell clonality assessment: past, present and future. J Clin Pathol. 2018;71:195-200.

  41. Salameire D, Solly F, Fabre B. Accurate detection of the tumor clone in peripheral Tcell lymphoma biopsies by flow cytometric analysis of TCR-V beta repertoire. Mod Pathol. 2012;25:1246-57.

  42. Villamizar-Rivera N, Olaya N. Análisis de clonalidad linfoide. Rev Med Inst Mex Seguro Soc. 2015;53(1):56-65.

  43. Villamizar-Rivera N, Olaya N. Determinación de la clonalidad en tejidos humanos. Iatreia. 2015;28(3):269-82. doi 10.17533/udea.iatreia.v28n3a05.

  44. Leprince BA, Mateo V, Lim A. Human TCR alpha/beta+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells. J Immunol. 2008;181:440-8.

  45. Lima M, Almeida J, Santos AH. Immuno phenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta (+) large granular lymphocytes: utility in assessing clonality and insights in to the pathogenesis of the disease. Am J Pathol. 2001;159:1861-8.

  46. Epling-Burnette PK. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood. 2004;103(9):3431-9.




2020     |     www.medigraphic.com